{"id":1975,"name":"RA Capital Management","slug":"ra-capital-management","website":"https://www.racap.com","hqGeo":"Boston, MA","stageFocus":["Seed","Pre-Seed"],"sectorTags":["Healthcare","Other"],"excludedSectors":[],"checkSizeMin":1000000,"checkSizeMax":5000000,"thesisSummary":"RA Capital specializes in identifying and supporting transformative life sciences ventures, with a deep focus on biotech and innovative pharmaceuticals.","thesisNarrative":null,"logoUrl":null,"aumUsd":12629842282,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"Spero Therapeutics","companyUrl":null,"stage":null,"sector":"Biotech","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Aimmune Therapeutics","companyUrl":null,"stage":null,"sector":"Pharmaceuticals","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Lusaris Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Eliem Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Aerovate Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Imbria Pharmaceuticals","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Athenen Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"RA Capital Planetary Health Fund, L.P.  (CIK 0001979194)","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"SEC Form D filing mentioning RA Capital Management","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"RA Capital Healthcare Fund LP  (CIK 0001315082)","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"SEC Form D filing mentioning RA Capital Management","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"RA Capital Planetary Health International Fund, L.P.  (CIK 0001979199)","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"SEC Form D filing mentioning RA Capital Management","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"RA CAPITAL HEALTHCARE INTERNATIONAL FUND LTD  (CIK 0001391647)","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"SEC Form D filing mentioning RA Capital Management","amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":11,"partners":[{"id":8980,"name":"Peter Kolchinsky","title":"Managing Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/peterkolchinsky","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":8972,"name":"Matthew Hammond","title":"Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/matthew-hammond-50445058","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":8973,"name":"Manas Adhikari","title":"Finance Director","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/manas-adhikari-a5554117a","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":8974,"name":"Shawn Valliere","title":"Head of Family Office","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/shawnvalliere","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":8975,"name":"Rebecca Silberman","title":"Investment Director","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/rebecca-silberman","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":8976,"name":"Shan Shan Wang","title":"Associate Director","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/shan-shan-wang-73484416a","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":8977,"name":"Brendan Joyce","title":"Tax Director","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/brendan-joyce-216b076","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":8978,"name":"Kate Moreau","title":"Director","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/kate-moreau-a183a438","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":8979,"name":"Kathryn Meng","title":"Investment Director","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/kathrynmeng","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":8981,"name":"Brent Sanders","title":"Chief Information Officer","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/brentsanders","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":13614,"name":"Laura Stoppel","title":"Partner","seniority":null,"focusTags":["public and private investments","Board Director for Artiva Biotherapeutics, Nimbus Therapeutics, and Acumen Pharmaceuticals"],"linkedinUrl":"https://www.linkedin.com/in/laura-stoppel-a5639125","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":"Laura Stoppel is a Partner on the Investment Team at RA Capital Management. Laura works on both public and private investments and serves as a Board Director for Artiva Biotherapeutics, Nimbus Therapeutics, and Acumen Pharmaceuticals. Previously, Laura covered hematologic malignancies, cell therapies, retinal diseases, and orphan neurodevelopmental disorders. Her graduate research investigated synaptic translation in syndromic autism. Laura holds a BA in Biology and Psychology from Harvard University and a PhD in Neuroscience from MIT.","recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":null,"investmentsLast12Months":0},"investorType":"vc","preferredApproach":"warm intro preferred","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":6492,"name":"Breed Reply","slug":"breed-reply","logoUrl":null,"website":"https://www.reply.com/","stageFocus":[],"sectorTags":["Healthcare","Security"],"hqGeo":null},{"id":6827,"name":"Force Over Mass","slug":"force-over-mass","logoUrl":null,"website":"https://www.fomcap.com/","stageFocus":[],"sectorTags":["AI / ML","Developer Tools","Other","Fintech","SaaS","Healthcare","EdTech"],"hqGeo":null},{"id":1548,"name":"Health Innovation Capital","slug":"health-innovation-capital","logoUrl":null,"website":"https://www.healthinnovation.vc/","stageFocus":["Seed","Pre-Seed"],"sectorTags":["Healthcare"],"hqGeo":"Boston, MA"},{"id":12096,"name":"TeleHealth Ventures","slug":"telehealth-ventures","logoUrl":null,"website":"https://telehealthventures.com","stageFocus":["Seed"],"sectorTags":["Other","Healthcare"],"hqGeo":"Austin, TX"},{"id":1369,"name":"Sonder Health Ventures","slug":"sonder-health-ventures","logoUrl":null,"website":"https://sondercapital.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Healthcare","Other"],"hqGeo":"Austin, TX, USA"},{"id":11533,"name":"Nova Health Fund","slug":"nova-health-fund","logoUrl":null,"website":"https://www.independenthealth.com/","stageFocus":["Seed","Series A"],"sectorTags":["Healthcare","Other"],"hqGeo":"Minneapolis, MN"}],"featuredIn":[{"slug":"seed","displayName":"Seed Investors","pageType":"stage"},{"slug":"healthcare","displayName":"Healthcare Investors","pageType":"industry"}],"fundraisingResources":[{"slug":"Finding-Investors-For-Startup-In-2026","title":"How to Find Investors for Your Startup in 2026 (Without Cold-Searching Databases)"},{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"},{"slug":"how-many-investors-should-you-pitch","title":"How Many Investors Should You Pitch? The Math Most Founders Get Wrong"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-07-09T12:54:37.620Z"}